Affiliation:
1. Department of Biotechnology Graduate school of Life Sciences & Biotechnology College of Life Sciences and Biotechnology Korea University Seoul 02846 Republic of Korea
2. Department of Food Bioscience and Technology College of Life Sciences and Biotechnology Korea University Seoul 02855 Republic of Korea
3. Interdisciplinary Program in Precision Public Hesalth Korea University Seoul 02846 Republic of Korea
4. BK21 Four Institute of Precision Public Health Korea University Seoul 02846 Republic of Korea
Abstract
ScopeThis study aims to investigate the anticancer properties of α‐ionone in squamous cell carcinoma (SCC).Methods and resultsThe expression of OR10A6 together with olfactory receptor signaling components is demonstrated in A431 human SCC cells via RT‐PCR and qRT‐PCR analysis. OR10A6 activation in A431 cells using the ligand α‐ionone inhibits proliferation and migration but induces apoptosis which is confirmed by proliferation assay, colony formation, and western blotting. The mechanism involves the core proteins of the Hippo pathway, where the phosphorylation of large tumor suppressor kinase (LATS), yes‐associated protein (YAP), and transcriptional coactivator with PDZ‐binding motif (TAZ) is confirmed by western blotting. However, the anticancer effects of α‐ionone are abrogated in A431 cells with OR10A6 gene knockdown. In A431 xenograft mouse model, the injection of α‐ionone suppresses tumor growth, induces apoptosis, and increases phosphorylation of the LATS‐YAP‐TAZ signaling axis in the Hippo pathway. None of these effects are observed in xenografted tumors with OR10A6 gene knockdown.ConclusionThese findings collectively demonstrate that activation of ectopic OR OR10A6 by α‐ionone in SCC cells stimulates the Hippo pathway and suppresses tumorigenesis both in vitro and in vivo, suggesting a novel therapeutic candidate for the treatment of SCC.
Funder
National Research Foundation of Korea